Precision Medicine Approach in Prostate Cancer

Area of Science:

• Oncology and Systems Biology
• Precision Medicine
• Molecular Imaging

Background:

• Prostate cancer is a leading cause of cancer death in men globally.
• High-grade or locally advanced prostate cancers can become lethal.
• Novel therapeutic strategies are crucial for improving patient survival and quality of life.

Purpose of the Study:

• To review the impact of multi-omics data in systems biology for precision medicine in prostate cancer.
• To highlight the integration of molecular imaging with high-throughput techniques.
• To discuss novel treatments targeting metabolic pathways in prostate cancer.

Main Methods:

• Review of current literature on multi-omics data and systems biology in prostate cancer.
• Emphasis on integrating genomics, transcriptomics, proteomics, metabolomics, epigenomics, and phenomics.
• Exploration of molecular imaging modalities and high-throughput techniques.

Main Results:

• Multi-omics data aids in disease sub-classification and personalized treatment guidance.
• Systems biology approaches unravel complex biological networks in prostate cancer.
• Identification of prognostic biomarkers and targeted drug candidates is facilitated.

Conclusions:

• Multi-omics data is pivotal for advancing precision medicine in prostate cancer.
• Integrating diverse data types enhances understanding of prostate cancer complexity.
• Targeting metabolic pathways offers promising avenues for new prostate cancer therapies.